Precision manufacturing for clinical-quality regenerative medicines

46Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

Abstract

Innovations in engineering applied to healthcare make a significant difference to people's lives. Market growth is guaranteed by demographics. Regulation and requirements for good manufacturing practice-extreme levels of repeatability and reliability-demand high-precision process and measurement solutions. Emerging technologies using living biological materials add complexity. This paper presents some results of work demonstrating the precision automated manufacture of living materials, particularly the expansion of populations of human stem cells for therapeutic use as regenerative medicines. The paper also describes quality engineering techniques for precision process design and improvement, and identifies the requirements for manufacturing technology and measurement systems evolution for such therapies. © 2012 The Royal Society.

Cite

CITATION STYLE

APA

Williams, D. J., Thomas, R. J., Hourd, P. C., Chandra, A., Ratcliffe, E., Liu, Y., … Archer, J. R. (2012). Precision manufacturing for clinical-quality regenerative medicines. In Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences (Vol. 370, pp. 3924–3949). Royal Society. https://doi.org/10.1098/rsta.2011.0049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free